Stock Taper 
SENZAR ASSET MANAGEMENT, LLC
Latest 13F filing data - Q2 2018
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Merck & Co., Inc. | MRK | 107.43K | $6.52M |
 MiMedx Group, Inc. | MDXG | 85.05K | $543K |
 Sanofi | SNY | 76.84K | $3.07M |
 AstraZeneca PLC | AZN | 71.4K | $2.51M |
 Protagonist Therapeutics, Inc. | PTGX | 61.3K | $412K |
 TG Therapeutics, Inc. | TGTX | 31.59K | $415K |
 Theravance Biopharma Inc | TBPH | 27.4K | $621K |
 CVS Health Corp. | CVS | 24.33K | $1.57M |
 Gilead Sciences, Inc. | GILD | 22.3K | $1.58M |
 Cigna Corporation | CI | 17.39K | $2.96M |
 Prothena Corporation plc | PRTA | 17.09K | $249K |
 AnaptysBio, Inc. | ANAB | 15.97K | $1.14M |
 McKesson Corporation | MCK | 7.5K | $1M |
 Alnylam Pharmaceuticals, Inc. | ALNY | 5.42K | $534K |
 Regeneron Pharmaceuticals, Inc. | REGN | 5.22K | $1.8M |
 United Therapeutics Corporation | UTHR | 2.63K | $297K |